Vectura Group Plc
| London Stock Exchange: VEC
Vectura Group Plc is a product development company, which focuses on the development of pharmaceutical therapies for the treatment of bronchopulmonary diseases. It manufactures novel therapeutic products and drug delivery systems. The company's main products target diseases such as asthma and chronic obstructive pulmonary disease. It is engaged in a single business activity of pharmaceuticals, which consists of the research, development and commercialization of pharmaceutical products. The company was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom.